Mechanistic target of rapamycin modulation: an emerging therapeutic approach in a wide variety of disease processes

Br J Clin Pharmacol. 2016 Nov;82(5):1156-1157. doi: 10.1111/bcp.13117.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacology
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / genetics
  • Drug Delivery Systems*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / genetics
  • Sirolimus / antagonists & inhibitors
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / drug effects*
  • TOR Serine-Threonine Kinases / genetics

Substances

  • Antibiotics, Antineoplastic
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus